Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-012647

Chief Executive Officer sold 4,548 shares at an average $202.15 ($919,374)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Leproust Emily M. · Chief Executive Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-05 Sale : show line 1 in the form 10b5-1 −1,840 $200.44 $368,806 565,468 D
2026-10-05 Sale : show line 2 in the form 10b5-1 −481 $201.26 $96,804 564,987 D
2026-10-05 Sale : show line 3 in the form 10b5-1 −1,017 $202.32 $205,763 563,970 D
2026-10-05 Sale : show line 4 in the form 10b5-1 −432 $203.61 $87,958 563,538 D
2026-10-05 Sale : show line 5 in the form 10b5-1 −290 $204.80 $59,392 563,248 D
2026-10-05 Sale : show line 6 in the form 10b5-1 −297 $205.78 $61,116 562,951 D
2026-10-05 Sale : show line 7 in the form 10b5-1 −146 $206.84 $30,199 562,805 D
2026-10-05 Sale : show line 8 in the form 10b5-1 −45 $207.46 $9,336 562,760 D
Open-market sales · 4,548 sh · avg $202.15 · $919,374
Loading xslF345X06/marketforms-74107.xml…